News About: Pharm. Industry
Drug adverse reactions reported the top with Viagra.
Viagra, an anti-impotence drug, has been at the top in the report of the drug adverse reactions since 2005 by 150 cases, which was 10% of the total number of drug adverse reaction reports.
Number of the drug adver...
KPIC urges government to withdraw 20% price cut plan of generic drugs
The Korea Pharmaceutical Industry Cooperative (KPIC) called on the government to immediately retract its new drug plan, under which the price of all generic drugs covered by national health insurance is to be unilater...
Yungjin Pharm introduces D-Pharm's new stroke medicationYungjin Pharm said on October 20 it had concluded an exclusive licensing agreement with D-Pharm, an Israel based drug company, to introduce D-Pharm's proprietary ethical agent (...
|
Korea United President receives Global CEO Award
Kang Duck-young, CEO of Korea United Pharm Inc., received Global CEO award from the Conference for Asia and Europe Federation at a grand hall of the Hankook Ildo on October 18 for his contribution to promoting the cou...
266 billion won of business losses on Bio test scandals.
The KPMA reported that the government administrative measures against 287 drugs in charge of the bio equivalency test frauds resulted in about 266 billion won of economic losses a year, which excepted other losses acc...
Korea drug industry highly interested in Vietnam markets.
Quite a number of local drug companies are trying to enter their business into the Vietnam as a bridgehead for the South East Asian markets. The company included Shinpoong, Korea United Pharm., Phil International, Dae...
Vaccines to compete for more customers
GlaxoSmithKline and Merck & Co., two of the world's biggest medicine companies, will be in a competition in Korea over their main vaccines cervical cancer vaccines and rotavirus vaccines. Both companies believe their...
Green Cross to develope anti-cancer genetic therapy.Green Cross has agreed with an exclusive distribution of JX-594, an anti-cancer genetic therapy by the use of recombinant vaccinia virus, with American Generics Biotherapeutics ...
|
Debates rekindled on government's stern measures on generic data fabrication
The controversy over the bioequivalence data fabrication has flared again following the government's unilateral administrative measure to cancel the licenses of generic drugs without lawful procedures.
In a stateme...
Drug industry no longer tolerable to government red tapes.
The pharmaceutical industry circles raised a serial of administrative lawsuits against the various government's restricted policies and measures, claiming that it played a stumbling block to the industrial development...
